Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays 'No longer looking for participants', indicating recruitment is closed, and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note; the older 'Intervention / Treatment' header formatting and the previous revision note (v3.5.5) were removed.SummaryDifference0.4%

- Check8 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a site version release. This change is a backend/UI update and does not modify the study details or data presented on the page.SummaryDifference0.1%

- Check15 days agoChange DetectedNo text changes were provided for this page. There are no updates to summarize.SummaryDifference0.1%

- Check23 days agoChange DetectedThere are no changes detected in the provided data. The study details page content remains unchanged, reflecting existing information about the Derazantinib trial for FGFR2-altered intrahepatic cholangiocarcinoma.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a small platform or template update rather than changes to the study details presented on the page.SummaryDifference0.1%

- Check37 days agoChange DetectedNo textual changes were reported for the study page. The content remains as shown in the current record.SummaryDifference0.1%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.